Aspreva Pharmaceuticals Drip Drip Drip (Nasdaq:ASPL)

Aspreva Pharmaceuticals (Nasdaq:ASPL, TSX:ASV) knows how to tease the investment community with the drip method. They announce on Feb 1 something called preliminary results and let some sales figures out. In the same release they announce that on Feb 8 full results will be released. Hmmm talk about seeding or is it juicing the ball.